Meta's Stock Has Rocketed Over 30% in the Past Month. Here's How the Embattled "Magnificent Seven" Company Completely Flipped the Script NASDAQ · Markets 29m ago
Silexion Doses First Patient In Phase 2/3 SIL204 Trial For Pancreatic Cancer NASDAQ · Markets 59m ago